JPRN-jRCT1091220034
Completed
未知
The effects of combined therapy for hypertension on arterial function
Masumi Ai, MD, PhDBioethics Research Center, Tokyo Medical and Dental University0 sites60 target enrollmentJanuary 12, 2010
Conditionshypertension, type 2 diabetes mellitus
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hypertension, type 2 diabetes mellitus
- Sponsor
- Masumi Ai, MD, PhDBioethics Research Center, Tokyo Medical and Dental University
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male and female patients with hypertension and type 2 diabetes, aged 20\~80
Exclusion Criteria
- •intolerance of the drugs (candesartan and amlodipine)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Combination of Antihypertensive therapy in the elderly, Multicenter Investigation <CAMUI> Multi-center randomized controlled study on efficacy of ARB/Diuretic mixture versus ARB/Ca channel blocker combination therapy to blood pressure or cognitive function in the elderly patients who have insufficient controlled hypertension in ARB monotherapyHypertensionJPRN-UMIN000001688Elderly Hypertension Conference200
Completed
Not Applicable
effect of antihypertensive combination therapy with either CCB or diuretics on irbesartan on hypertensive patient with metabolic syndrome:A randomised controlled trialhypertensive patient with metabolic syndoromeJPRN-UMIN000003458Kanazawa Medical University Diabetes & Endocrinology40
Not yet recruiting
Phase 4
Effect Of Sarpagandha Vati and Haritaki churna in hypertensioCTRI/2024/05/067985Ch Brahm Prakash Ayurved Charak Sansthan
Completed
Phase 4
Antihypertensive effect of combination therapy of telmisartan and low dose hydrochrolthiazide in hypertemnsive patientsJPRN-UMIN000000798on profit Organization LINE60
Completed
Phase 4
Comparing anti-hypertensive combination therapy of fixed dose losartan and hydrochlorothiazide(HCTZ) versus angiotensin receptor blocker(ARB) and calcium channel blocker(CCB) on hypertensive patients whose blood pressures don't lower enough,effect and influence of metabolic system trial.HypertensionJPRN-UMIN000001692Hypertension and Metabolism Study group in East Saitama300